Elizabeth Messulam
Psychiatry · Augusta, GANPI 1922083252
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 325 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,987 and has fallen 62.2% since, to $751 in 2025. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $28.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$2K
- Ironshore Pharmaceuticals Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$1K
- AbbVie$670
- Supernus Pharmaceuticals, Inc.$669
- plus $2K from 14 others
What the payments were for
- Food & beverage$9,255100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 61 | $1,791 |
| Ironshore Pharmaceuticals Inc. | 57 | $1,353 |
| Otsuka America Pharmaceutical, Inc. | 26 | $1,159 |
| Johnson & Johnson | 54 | $1,137 |
| AbbVie(2 entities) | 25 | $670 |
| Supernus Pharmaceuticals, Inc. | 23 | $669 |
| Sunovion Pharmaceuticals Inc. | 33 | $630 |
| Neurocrine Biosciences, Inc. | 10 | $277 |
| E.r. Squibb & Sons, L.L.C. | 3 | $275 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $269 |
| Vanda Pharmaceuticals Inc. | 2 | $250 |
| Teva Pharmaceuticals USA, Inc. | 4 | $245 |
| Axsome Therapeutics, Inc. | 2 | $194 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $144 |
| Corium, LLC | 11 | $78 |
| Indivior Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,808
- LYBALVI$492
- ARISTADA INITIO$452
- ABILIFY MAINTENA$447
- JORNAY PM$378
- QELBREE$371
- COBENFY$252
- Fanapt$250
- CAPLYTA$237
- REXULTI$235
- VRAYLAR$222
- Jornay PM 20mg capsules (Bottle of 100)$183
- LATUDA$122
- INGREZZA$122
- INVEGA SUSTENNA$121
- ABILIFY ASIMTUFII$121
- INVEGA$120
- UZEDY$109
- Auvelity$108
- AUSTEDO$102
How this compares
$9,266 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone | 16 | $67 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Augusta
- Marshall BedderAugusta$182K
- William McCallAugusta$63K
- Joseph McEvoyAugusta$36K
- Mary TysonAugusta$17K
- Prakash MeraiAugusta$13K
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Michael BanovMarietta$733K
- Ben HunterBrookhaven$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.